Tag : biopharmaceutical

Clinical Research, Pharma & Healthcare Financing

Nuravax, IMM to Present Alzheimer’s Vaccine Data at CTAD 2025

PR Newswire
by PR Newswire086
Two oral presentations to highlight the safety, immunogenicity, and future development of AV-1959R for primary and secondary prevention of Alzheimer’s disease Nuravax Inc., a clinical-stage...
Clinical Research, Pharma & Healthcare Financing

IASO Bio Reports Positive MS Data for Equecabtagene at EAN Congress

PR Newswire
by PR Newswire0116
IASO Biotherapeutics (“IASO Bio”), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced that results...
Clinical Research, Pharma & Healthcare Financing

XellSmart’s iPSC Therapy for Spinal Injury Approved for FDA Trial

PR Newswire
by PR Newswire0160
In May 2025, XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. officially announced that XellSmart-developed off-the-shelf allogeneic iPSC-derived subtype-specific neural regenerative cell therapy has received official approval from both China’s National...
Clinical Research, Pharma & Healthcare Financing

TFS HealthScience expands collaboration with Oncomatryx for OMTX705 trial

PR Newswire
by PR Newswire0145
TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), is deepening its collaboration with Oncomatryx, a biopharmaceutical company developing novel antibody-drug conjugates (ADCs) targeting...
Clinical Research, Pharma & Healthcare Financing

Humanetics Chooses Lifecore for BIO 300 CDMO Services

GlobeNewswire
by GlobeNewswire0121
Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM) Lifecore to Carry Out Tech Transfer and Analytical...